The first three hybrids of Bt cotton developed in India by
Mahyco Monsanto Biotech Limited (MMBL)
Bt cotton is a genetically modified organism (GMO) cotton variety that produces an insecticide to combat bollworm, an insect pest that is highly destructive to cotton crops. The modification involves the insertion of genes from the bacterium \(\text{Bacillus thuringiensis (Bt)}\) into the cotton genome. These genes produce toxin proteins, specifically delta-endotoxins, which are toxic to certain insect larvae, including the cotton bollworm (\(\text{Helicoverpa armigera)}\).
The development and introduction of Bt cotton have significantly impacted cotton cultivation, particularly in countries like India, by reducing the need for chemical pesticides targeted at bollworms, thereby potentially lowering farming costs and environmental impact.
In India, the first steps towards commercially developing and introducing Bt cotton hybrids were taken by Mahyco Monsanto Biotech Limited (MMBL). MMBL was a joint venture between the Indian seed company Maharashtra Hybrid Seeds Company (Mahyco) and the US-based biotechnology giant Monsanto.
MMBL was instrumental in developing and obtaining regulatory approval for the first Bt cotton hybrids in India, utilizing Monsanto's Bollgard technology. The first three hybrids of Bt cotton introduced in India were indeed developed by this joint venture. These early hybrids paved the way for wider adoption of Bt cotton technology across the country.
Therefore, the first three hybrids of Bt cotton developed in India were a result of the efforts by Mahyco Monsanto Biotech Limited (MMBL).
Select wrong statement:
Mahabeej Biotechnology Center, Nagpur's state-of-art tissue culture laboratory produces ________ on large scale.
_________ is known as Biological containment.
The first vaccine developed from minced chick tissue against _________ found enormous application in tropical countries.
_________ can be sometimes used to determine percentage paternity of a child.